Biofrontera Inc. (BFRI) stock

BFRINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRIW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 9/30

$0.93−0.01 (-1.24%)

Close on Nov 12, 2026Market cap $13.75MP/E –Yield –

Biofrontera gross margin

Gross margin is gross profit as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2021	Sep 30, 2021	99.1%	–
Q3 FY2020	Sep 30, 2020	86.3%	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BFRI.

Revenue growth17.8% · median 15.5%

Operating margin-14.2% · median -42.9%

Net margin-13.8% · median -7.3%

Advertisement
300 × 250

See a number that looks wrong?